FOR 926 | 2014

Publications 2014

Ativie F, Albayram O, Bach K, Pradier B, Zimmer A, Bilkei-Gorzo A. (2014). Enhanced microglial activity in FAAH-/- animals. Life Sci, 2014 Dec 20. pii: S0024-3205(14)00979-5. doi: 10.1016/j.lfs.2014.12.016. [Epub ahead of print].

Heinemann JC, Duerr GD, Keppel K, Breitbach M, Fleischmann BK, Zimmer A, Wehner S, Welz A, Dewald O. (2014). CB2 receptor-mediated effects of pro-inflammatory macrophages influence survival of cardiomyocytes. Life Sci, pii: S0024-3205(14)00948-5. doi: 10.1016/j.lfs.2014.11.027. [Epub ahead of print].

Duerr GD, Heinemann JC, Gestrich C, Heuft T, Klaas T, Keppel K, Roell W, Klein A, Zimmer A, Velten M, Kilic A, Bindila L, Lutz B, Dewald O. (2014). Impaired border zone formation and adverse remodeling after reperfused myocardial infarction in cannabinoid CB2 receptor deficient mice. Life Sci, 2014 Nov 14. pii: S0024-3205(14)00915-1. doi: 10.1016/j.lfs.2014.11.005. [Epub ahead of print].

Hiebel C, Kromm T, Stark M, Behl C. (2014). Cannabinoid receptor 1 modulates the autophagic flux independent of mTOR- and BECLIN1-complex. J Neurochem, 131(4):484-97.

Duerr GD, Heinemann JC, Suchan G, Kolobara E, Wenzel D, Geisen C, Matthey M, Passe-Tietjen K, Mahmud W, Ghanem A, Tiemann K, Alferink J, Burgdorf S, Buchalla R, Zimmer A, Lutz B, Welz A, Fleischmann BK, Dewald O. (2014). The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. Basic Res Cardiol, 109(4):425.

Jergas B, Schulte K, Bindila L, Lutz B, Schlicker E (2014). O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol, 387(7):621-8.

Friemel CM, Zimmer A, Schneider M. (2014). The CB1 Receptor as an Important Mediator of Hedonic Reward Processing. Neuropsychopharmacology, 39(10):2387-96.

Bilkei-Gorzo A. (2014). Genetic mouse models of brain ageing and Alzheimer's disease. Pharmacol Ther, 142(2):244-57.